Corteva
NYSE: CTVA
Stock price
87.3 USD
(+Infinity%) NaN day
Financial Performance
5Y price score: 150
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 214.4%
US$ Per
Share
By default your notes are visible only to you.
60.5
52-week range
88.2
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
3.5 %
Dividend Yield TTM
0.8 %
Market cap $
$ 58,388
Price / Earnings TTM
51.4
Price / Book TTM
2.4
PEG TTM
2.2
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
20.3 %
116.2 %
214.4 %
Free cash flow per share growth
88 %
97.7 %
-
Earnings per share growth
23.1 %
75.8 %
-
Business Summary:
Latest Earnings Call Takeaways
2026 Q1 (May 6, 2026)
1) Strategy & Leadership
- Corteva is on track for a separation in Q4 2026, with significant milestones achieved, including the announcement of the new CEO for the crop protection business, Luke Kism.
- The new seed and genetics company will be named Vylor, reflecting a commitment to innovation and agricultural science.
- The company is focused on becoming a leader in soybean technology in Brazil, with expectations for trait penetration to reach double digits this year.
2) Financial & Segment Results
- Q1 2026 saw a 21% increase in EBITDA year-over-year, with operating EBITDA exceeding $1.4 billion and margins expanding by 240 basis points to over 29%.
- Organic sales rose 7%, driven by a 9% increase in seed and a 4% increase in crop protection.
- Currency fluctuations provided a 4% tailwind to sales, while seed price mix improved by 3%.
- The company reaffirmed its full-year guidance, expecting operating EBITDA between $4 billion and $4.2 billion and operating EPS of $3.45 to $3.70.
3) Problems / Headwinds
- Farmers are cautious and value-driven, with a projected 3% to 4% reduction in corn acres due to a shift towards soybeans.
- Higher oil prices are expected to create a $40 million headwind in the second half of the year, alongside ongoing geopolitical tensions affecting supply chains.
- Crop protection pricing is under pressure, with expectations of low single-digit declines year-over-year, although volume growth is anticipated.
4) Operational or Product Plans
- Corteva is making strides towards becoming royalty positive, with a significant decrease in net royalty expenses.
- The company is focused on expanding its biologicals portfolio, particularly in Latin America, with products like Utrisha and BlueN driving growth.
- The upcoming launch of proprietary hybrid wheat technology and advancements in gene editing are key components of Corteva's long-term growth strategy.
5) Guidance & Outlook / Investor Angle
- The company expects continued momentum in the second half of 2026, particularly in crop protection volumes driven by Latin America.
- Investors should focus on Corteva's strong product pipeline and cost productivity initiatives, which are expected to enhance margins and drive value creation.
- The separation into two distinct entities is anticipated to unlock further strategic opportunities and improve capital allocation for both businesses.
Bottom line: Corteva is positioned for strong growth in 2026, supported by robust demand for its seed and crop protection products, strategic advancements in technology, and a favorable separation plan that aims to enhance shareholder value.
Annual Reports, Presentations And IR Contacts
Go to the websiteCorteva — Financial Overview, Stock Price, Market Cap
Corteva is a company. Founded in 2019. As of July 20, 2026, the company's market capitalization is $58387986000 with a current stock price of $87.30.
